Morgan Stanley
CNLM

Morgan Stanley’s CB PHARMA ACQUISISTION CORP SHS (CYM) CNLM Stock Holding History

Morgan Stanley’s Portfolio CNLM Stock Details CNLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9
Closed – – 6862
2016
Q1 		$0 Sell
9
-1
-10% -$10 ﹤0.01% 6900
2015
Q4 		$0 Buy
+10
New +$99 ﹤0.01% 6966

Morgan Stanley's CNLM Position: Q2 2016 in Review

Morgan Stanley sold out of CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) in Q2 2016, closing a stake of 9 shares.

Morgan Stanley first reported a position in CNLM in Q4 2015 and held it in 2 quarters. The position peaked at $0 in Q1 2016. 0 funds tracked by Wall St. Rank hold CNLM as of Q2 2016.

  • Morgan Stanley reported no remaining CB PHARMA ACQUISISTION CORP SHS (CYM) position as of Q2 2016 after selling out during the quarter.
  • Morgan Stanley sold 9 CB PHARMA ACQUISISTION CORP SHS (CYM) shares in Q2 2016.
  • Morgan Stanley first reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) in Q4 2015 and held it in 2 quarters.
  • Morgan Stanley's CB PHARMA ACQUISISTION CORP SHS (CYM) position peaked at $0 in Q1 2016.
  • 0 funds tracked by Wall St. Rank held CB PHARMA ACQUISISTION CORP SHS (CYM) as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.